IL6 and Parkinson disease: Measured levels of IL-6 in serum from participants with PRKN/PINK1 mutations determined that individuals with biallelic PRKN/PINK1 mutations had higher IL-6 levels than healthy controls, lending support to the idea that inflammation plays a role in PRKN/PINK1-related PD.